Does CABAZITAXEL Cause Interstitial lung disease? 40 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Interstitial lung disease have been filed in association with CABAZITAXEL (Jevtana). This represents 1.6% of all adverse event reports for CABAZITAXEL.
40
Reports of Interstitial lung disease with CABAZITAXEL
1.6%
of all CABAZITAXEL reports
12
Deaths
20
Hospitalizations
How Dangerous Is Interstitial lung disease From CABAZITAXEL?
Of the 40 reports, 12 (30.0%) resulted in death, 20 (50.0%) required hospitalization, and 4 (10.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CABAZITAXEL Alternatives Have Lower Interstitial lung disease Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE